Tomorrow’s treatment today.

It Starts With You
Let's Do This Together

Welcome to K2 Medical Research, a privately-owned clinical research facility in the greater Orlando area. We specialize in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of our participants. Here at K2, we are committed to fighting the diseases that plague our loved ones and ourselves. By harnessing the power of advanced clinical research and connecting our patients with the treatments of tomorrow, we can improve the health of our local communities, and by extent, the population of our world.

Years of Experience

5,000+ Trials Completed

We provide an extensive list of open studies, please contact our offices to participate.

70+ Years of Experience

A team of highly trained doctors and staff to provide you with the best care.

100% Patient Satisfaction

Find a clinical study that's right for you. We are ready to answer any questions you might have.

Connecting Research

High-Quality Research Network that spans from the North Pacific to the Atlantic Oceans.

Dedicated to Diversity and Inclusion

Over 20K Participants

Multiculturalism and inclusion are important concepts here at K2. We understand the significance of representation of all populations in clinical research and are aware of the current lack of diversity in trial participants. We endeavor to change this. We reject a set-it and forget-it mentality when it comes to equity and justice; instead, we aim to use these ideas as living, working concepts that inform our daily interactions with one another, with patients and with the community at large. Find out more about what we are doing to promote diversity in our clinical trials.

Clinical Research as a Care Option

Clinical Research as a Care Option (CRAACO) is a concept that is revolutionizing health care as we know it. Considering the use of clinical trials as a tool to supplement and/or replace conventional healthcare is a radical notion, but one that stands to benefit patients, physicians, and the research community as a whole. Some of these benefits include faster drug development, and for patients, a more cost-effective approach with better treatment outcomes. Here at K2 Medical Research, we are fully onboard and are collaborating with local practices to help make this innovative idea a reality for our patients. While traditional healthcare presents many well-known challenges to patients seeking treatment, participating in a clinical research trial offers many practical solutions. By participating in a research study with K2, participants can expect to:

Areas of Research

We do our best to stay relevant to the needs of our patients using advanced technology that helps us better diagnose and treat conditions and diseases. Our office features innovative technology that makes it possible for us to provide unsurpassed patient care not available just a few years ago.

Therapeutic Treatments

Latest research and new treatments for liver disease such as Non-alcoholic Steatohepatitis (NASH) and Non-alcoholic fatty liver disease (NAFLD).

Research aimed to further understand and treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s Disease.

Research and treatment options of depressive disorders in the chronic pain patient such as depression and anxiety.

Studies range from genetic and molecular studies of the mechanisms of cardiovascular disease to studies of vascular properties, lifestyle interventions, and responsiveness to preventive pharmacotherapy.

In the United States, the most common endocrine disease is diabetes. There are many others such as Addison’s Disease, Cushing’s Syndrome, Graves’ Disease and Hashimoto’s Thyroiditis to consider clinical trial participation.

Autoimmune rheumatic diseases (ARDs) are a diverse group of conditions that primarily affect the joints, bones, muscle, and connective tissue such as Rheumatoid Arthritis (RA).

Digestive diseases research for disorders of the digestive tract, which is sometimes called the gastrointestinal (GI) tract such as Gastroesophageal Reflux Disease (GERD), Crohn's Disease Ulcerative Colitis (UC). Irritable Bowel Syndrome (IBS) and Diverticulitis.

Clinical trials that are conducted to find better tests or procedures for diagnosing a particular disease or condition.

Innovative translational research uses biomarkers to accelerate or aid in diagnosis or monitoring and provide insight into “personalized” medicine. A biomarker is a quantifiable biological parameter (such as blood pressure, heart rate, blood and genetic test, and x-rays) that are measured and evaluated over time as an indicator of normal biological, pathogenic, or pharmacologic responses to a therapeutic intervention.

Nutrition studies the relationship between foods and its effect on an individual's health. Nutrition considers topics such as obesity, malnutrition, food insecurity and nutritional deficiencies.

Research discovering immunity and treatments for Covid-19

Brandon Lenox DO, MPH

Principal Investigator

Brandon Lenox, DO is a board-certified anesthesiologist and epidemiologist with a long and distinguished career in medicine.  As Chief Medical Officer of K2 Medical Research, Dr. Lenox provides the K2 team with over 20 years’ experience in clinical trials, medical research, and clinical practice.  After earning his graduate degree in public health, he went on to graduate from Nova Southeastern University College of Osteopathic Medicine with highest honors then completed his residency training at Johns Hopkins University School of Medicine.

"The staff is wonderful, professional and knowledgeable. They provide you with the best service when possible! Whenever I had a question, they were ready to answer. Quick responses and follow ups, and always gives the best advice. "

Study Participant, August 2021


Help us, help you meet your drug development goals.

Still curious? Read the latest news and press releases about our office.

Changing Medicine

May 10, 2021

Joining Studies & Team

June 2, 2021

Advancing Technology

April 19, 2021
Skip to content